Universities and companies that turn discoveries into medicines in Seattle have searched for “safe harbor” from the White ...

Good morning, Boston, and happy Friday. Here are the five things you need to know in local business news to start your busy day, including Moderna's cost cuts, "misunderstood" Wayfair, the highest ...

Among three Korean biotech companies slated to sell shares on the Korea Exchange this month, Immuneoncia Therapeutics Inc. is ...

Though optimistic, speakers at the recent LSX World Congress in London, UK, recognised that recent turbulence in the wake of ...

Over the past few weeks, a new crop of blank-check companies have announced plans to merge with target companies in areas ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T-cell ...

Zurich-based start-up Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

As well as identifying novel drug targets and therapeutics, the partnership will explore collaboration in R&D with leading academic and research organizations globally and support the development of ...

Design software startup Figma announced Tuesday it has filed its confidential paperwork for an IPO. We won’t know more until that paperwork becomes public, which, best-case scenario would be in ...